BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11861302)

  • 1. HPA-1a phenotype-genotype discrepancy reveals a naturally occurring Arg93Gln substitution in the platelet beta 3 integrin that disrupts the HPA-1a epitope.
    Watkins NA; Schaffner-Reckinger E; Allen DL; Howkins GJ; Brons NH; Smith GA; Metcalfe P; Murphy MF; Kieffer N; Ouwehand WH
    Blood; 2002 Mar; 99(5):1833-9. PubMed ID: 11861302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A naturally occurring LeuVal mutation in beta3-integrin impairs the HPA-1a epitope: the third allele of HPA-1.
    Santoso S; Kroll H; Andrei-Selmer CL; Socher I; Rankin A; Kretzschmar E; Watkins NA; Ouwehand WH
    Transfusion; 2006 May; 46(5):790-9. PubMed ID: 16686847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human platelet antigen 1a epitopes are dependent on the cation-regulated conformation of integrin α(IIb)β(3) (GPIIb/IIIa).
    Allen DL; Abrahamsson S; Murphy MF; Roberts DJ
    J Immunol Methods; 2012 Jan; 375(1-2):166-75. PubMed ID: 22036924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic and structural analysis of eight novel domain-deletion beta3 integrin peptides designed for detection of HPA-1 antibodies.
    Stafford P; Ghevaert C; Campbell K; Proulx C; Smith G; Williamson LM; Ranasinghe E; Watkins NA; Huntington JA; Ouwehand WH
    J Thromb Haemost; 2008 Feb; 6(2):366-75. PubMed ID: 18045240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the alloreactive helper T-cell response to the platelet membrane glycoprotein IIIa (integrin-beta3) in human platelet antigen-1a alloimmunized human platelet antigen-1b1b women.
    Sukati H; Bessos H; Barker RN; Urbaniak SJ
    Transfusion; 2005 Jul; 45(7):1165-77. PubMed ID: 15987363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes.
    Zhang N; Zhi H; Curtis BR; Rao S; Jobaliya C; Poncz M; French DL; Newman PJ
    Blood; 2016 Feb; 127(6):675-80. PubMed ID: 26634302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution mapping of the polyclonal immune response to the human platelet alloantigen HPA-1a (Pl
    Zhi H; Ahlen MT; Thinn AMM; Weiler H; Curtis BR; Skogen B; Zhu J; Newman PJ
    Blood Adv; 2018 Nov; 2(21):3001-3011. PubMed ID: 30413435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three novel beta3 domain-deletion peptides for the sensitive and specific detection of HPA-4 and six low frequency beta3-HPA antibodies.
    Stafford P; Garner SF; Huiskes E; Kaplan C; Kekomaki R; Santoso S; Tsuno NH; Watkins NA; Ouwehand WH
    J Thromb Haemost; 2008 Feb; 6(2):376-83. PubMed ID: 18031296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of recombinant IgG antibodies against the leucine-33 form of the platelet beta3 integrin (HPA-1a) on platelet function.
    Joutsi-Korhonen L; Preston S; Smethurst PA; Ijsseldijk M; Schaffner-Reckinger E; Armour KL; Watkins NA; Clark MR; de Groot PG; Farndale RW; Ouwehand WH; Williamson LM
    Thromb Haemost; 2004 Apr; 91(4):743-54. PubMed ID: 15045136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a human platelet alloantigen-1a epitope(s) within murine glycoprotein IIIa: identification of residues critical to the conformation of the antibody binding site(s).
    Barron-Casella EA; Nebbia G; Rogers OC; King KE; Kickler TS; Casella JF
    Blood; 1999 May; 93(9):2959-67. PubMed ID: 10216091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid phenotyping of HPA-1a using either diabody-based hemagglutination or recombinant IgG1-based assays.
    Watkins NA; Armour KL; Smethurst PA; Metcalfe P; Scott ML; Hughes DL; Smith GA; Williamson LM; Clark MR; Ouwehand WH
    Transfusion; 1999 Jul; 39(7):781-9. PubMed ID: 10413288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the long-range GPIIIa Cys(5)-Cys(435) disulfide bond results in the production of constitutively active GPIIb-IIIa (alpha(IIb)beta(3)) integrin complexes.
    Sun QH; Liu CY; Wang R; Paddock C; Newman PJ
    Blood; 2002 Sep; 100(6):2094-101. PubMed ID: 12200372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional platelet fibrinogen receptor with a deletion in the cysteine-rich repeat region of the beta(3) integrin: the Oe(a) alloantigen in neonatal alloimmune thrombocytopenia.
    Santoso S; Kiefel V; Richter IG; Sachs UJ; Rahman A; Carl B; Kroll H
    Blood; 2002 Feb; 99(4):1205-14. PubMed ID: 11830467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three amino acid deletion in glycoprotein IIIa is responsible for type I Glanzmann's thrombasthenia: importance of residues Ile325Pro326Gly327 for beta3 integrin subunit association.
    Morel-Kopp MC; Kaplan C; Proulle V; Jallu V; Melchior C; Peyruchaud O; Aurousseau MH; Kieffer N
    Blood; 1997 Jul; 90(2):669-77. PubMed ID: 9226167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing conformational changes in the I-like domain and the cysteine-rich repeat of human beta 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in alphaIIbbeta3 activation.
    Chen P; Melchior C; Brons NH; Schlegel N; Caen J; Kieffer N
    J Biol Chem; 2001 Oct; 276(42):38628-35. PubMed ID: 11507099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe fetomaternal alloimmune thrombocytopenia due to anti-human platelet antigen (HPA)-1a in a mother with a rare and silenced ITGB3*0101 (GPIIIa) allele.
    Smith GA; Rankin A; Riddle C; Cheetham-Wilkinson C; Ranasinghe E; Ouwehand WH; Watkins NA
    Vox Sang; 2007 Nov; 93(4):325-30. PubMed ID: 18070277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid and specific whole blood HPA-1 phenotyping by flow cytometry using two commercialized monoclonal antibodies directed against GP IIIa and GP IIb-IIIa complexes.
    Sorel N; Brabant S; Christiaens L; Brizard A; Mauco G; Macchi L
    Br J Haematol; 2004 Jan; 124(2):221-3. PubMed ID: 14687033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new platelet polymorphism Duv(a+), localized within the RGD binding domain of glycoprotein IIIa, is associated with neonatal thrombocytopenia.
    Jallu V; Meunier M; Brément M; Kaplan C
    Blood; 2002 Jun; 99(12):4449-56. PubMed ID: 12036875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine 752 in the cytoplasmic domain of the beta 3 integrin subunit is not required for alpha v beta 3 postreceptor signaling events.
    Kieffer N; Melchior C; Guinet JM; Michels S; Gouon V; Bron N
    Cell Adhes Commun; 1996 Jul; 4(1):25-39. PubMed ID: 8870971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max a) is an important cause of neonatal alloimmune thrombocytopenia.
    Peterson JA; Balthazor SM; Curtis BR; McFarland JG; Aster RH
    Transfusion; 2005 Sep; 45(9):1487-95. PubMed ID: 16131382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.